Overview

A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Determine efficacy of the latanoprost punctal plug. Effect of configuration of L-PPDS placement on efficacy will also be examined.
Phase:
Phase 2
Details
Lead Sponsor:
Mati Therapeutics Inc.
Treatments:
Latanoprost
Maleic acid
Timolol